kabutan

I'rom Group Co.,Ltd.(2372) Summary

2372
I'rom Group Co.,Ltd.
JPY
0
(0.00%)
May 9, 3:30 pm JST
USD
May 9, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
PBR
2.58
Yield
ー%
Margin Trading Ratio
Stock Price
May 9, 2025
Opening May 9, 9:00 am
2,790 JPY 19.11 USD
Previous Close May 8
2,790 JPY 19.34 USD
High May 9, 3:24 pm
2,793 JPY 19.20 USD
Low May 9, 9:00 am
2,790 JPY 19.10 USD
Volume
22,800
Trading Value
0.06B JPY 0.44M USD
VWAP
2790.37 JPY 19.18 USD
Minimum Trading Value
279,000 JPY 1,918 USD
Market Cap
0.03T JPY 0.24B USD
Number of Trades
34
Liquidity & Number of Trades
As of May 9, 2025
Liquidity
Mid
1-Year Average
117
1-Year High May 16, 2024
1,918
Margin Trading
Date Short Interest Long Margin Positions Ratio
May 2, 2025 0 600
Apr 25, 2025 0 1,700
Apr 18, 2025 0 2,700
Apr 11, 2025 0 3,600
Apr 4, 2025 0 5,600
Company Profile
I'rom Group Co., Ltd. primarily focuses on supporting clinical trials for medical institutions. The company also engages in contract pharmaceutical development and clinic mall operations.
Sector
Services
I'rom Group Co., Ltd. operates broadly in the medical field, centering on SMO (Site Management Organization) services, while also providing CRO (Contract Research Organization) services, advanced medical care, drug discovery, and medical support services. In its SMO business, the company contracts and supports clinical trial operations from medical institutions. The CRO division conducts early-stage clinical trials, supporting global development for pharmaceutical companies. The advanced medical care division develops vaccines and gene therapy products using vector technology, conducts research and development in regenerative medicine, and offers contract manufacturing of clinical vectors. In drug discovery, I'rom Group collaborates on developing biosimilars and other pharmaceuticals. The medical support division operates clinic malls and provides medical business consulting services.